Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21971890 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Pharmacokinetic and Efficacy Study of Nordihydroguaiaretic Acid (NDGA) in Non Metastatic Recurrent Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: Nordihydroguaiaretic Acid (NDGA)

Indicates status has not been verified in more than two years